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Conclusion. Online double-pool urea kinetic modeling gaveUrea as a marker of adequacy in hemodialysis: Lesson from
a new insight in urea kinetic modeling approach. Urea dynam-in vivo urea dynamics monitoring.
ics fit perfectly a double-compartment model structure. Acces-Background. “Dialysis dose,” a concept developed by Sar-
sible extracellular volume to hemodialysis is smaller than ex-gent and Gotch based on urea kinetic modeling, is a useful
pected. The in vivo urea mass transfer coefficient must beand recognized tool that is used to quantitate and optimize a
dialysis-efficacy program. However, it has been shown that considered as an individual and variable characteristic of
oversimplification of the “dialysis adequacy” concept to the ESRD patients that should be taken into consideration when
Kt/V index might lead to dramatic underdialysis and subse- prescribing the hemodialysis schedule.
quent deleterious consequences on morbidity and mortality of
dialysis patients. With this perspective, the determination of
Kt/V must be very cautious and rely on accurate measurement
The concept of dialysis adequacy was developed inof postdialysis urea concentration and its use integrated as a
tool in a quality-assurance process. the early 1970s to assess treatment efficacy of end-stage
Methods. In this study, we analyzed urea dynamics by means renal disease (ESRD) patients [1]. Basically, it was im-
of a blood side (ultrafiltrate) continuous online urea monitoring plied that the renal replacement therapy (RRT) program
system interfaced with a two-pool model hosted in a microcom-
should cover vital metabolic needs of ESRD patients.puter. The study was designed to provide instantaneous dialysis
However, because of the complexity of uremic-relatedperformances (body and dialyzer clearances, dialyzer mass
transfer coefficient) and to determine the in vivo functional metabolic disturbances, it was soon recognized that se-
permeability characteristics of the patient [intercompartment lection of vital criteria must be made. Accordingly, spe-
urea mass transfer coefficient (Kc)]. Thirteen end-stage renal cific “markers” reflecting main imbalances of the “inter-disease patients (age 54 6 16 years; 12 male and 1 female) were
nal milieu” were held for their pertinence and predictivestudied during nine consecutive dialysis sessions (3 weeks).
value on morbidity and/or mortality of ESRD patientsResults. Urea kinetics obtained from the urea monitoring
system fitted closely the urea kinetic modeling prediction, con- [2]. Dialysis adequacy was considered as achieved when
firming the validity of the double-pool model structure. Effec- selected criteria of efficacy were reached. Although effi-
tive in vivo urea mass transfer coefficient averaged 912 6 235
cient in predicting treatment adequacy and success rate,mL/min/1.73 m2, a value close to those reported with more
this “targeting” approach based on selected parametersinvasive methods. Large variations ranging from 363 to 1249
mL/min were observed among patients, confirming very large was shown to be highly subjective and not able to opti-
interindividual patient permeability differences. Interestingly, mize treatment performances.
the urea mass transfer coefficient was inversely correlated with Sargent and Gotch introduced urea kinetic modelingthe postdialysis rebound values. Intraindividual variations were
(UKM) in the late 1970s as a complementary tool toalso noted as a function of time denoting functional changes
quantitate and to optimize dialysis efficacy programs [3].in urea mass transfer coefficient values. The urea distribution
volume was 38.1 6 7, 8 L (53 6 8% body weight). V1 referring The UKM concept, derived from pharmacokinetic prin-
to the extracellular volume and V2 to the intracellular volume ciples, was established with urea concentrations (pre/
were 9 6 2 L (13 6 2% body weight) and 29.2 6 6.6 L (41 6 1.3%
post and predialysis) induced by intermittent hemodialy-body wt), respectively. The extracellular/intracellular volume
sis and basic parameters such as body weight (pre andratio was 0.31 (approximately one third) and was not as usually
defined by the paradigm 1/2 ratio. post), time duration (on and off dialysis periods), dia-
lyzer clearance, and residual kidney function to calculate
modeled parameters such as urea volume distribution,
Key words: dialysis adequacy, kinetic modeling of urea, intracorporeal
body clearance, and protein catabolic rate (nPCR) [4].urea mass transfer coefficient, hemodiafiltration, end-stage renal dis-
ease. Later on, the concept of “dialysis dose” delivery to hemo-
dialysis patient was established as the normalized bodyÓ 2000 by the International Society of Nephrology
S-28
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urea clearance (or fraction of body urea volume cleared
per session), best known as the Kt/V index [5]. In this
relationship, K stands for the instantaneous body urea
clearance, t for the duration of the dialysis session, and
V for the urea distribution volume that is equivalent to
total body water. The urea mass generated during the
interdialytic period was used to estimate the nPCR, a
surrogate of dietary protein intake in metabolically sta-
ble HD patients. In the meantime, UKM applied to a Fig. 1. Two compartment model of urea kinetics. Abbreviations are:
large cohort of patients in prospective and controlled Kc, intercompartmental mass transfer coefficient; Keff, effective dialyzer
clearance; V1 and V2, volumes of accessible and remote pool, respec-studies has confirmed its usefulness in quality-control
tively; G, urea generation rate.processes and its powerful predictive value in patient
outcome [6]. Urea was finally recognized as a surrogate
of “uremic toxins” and was used through kinetic analysis
as a cost-competitive marker with multipurpose signifi- dialysis quantitation results to the indirect ones estimated
cance [7]. By providing simultaneous information on di- from bedside formulae.
alysis efficacy, dietary protein intake and the uremia
intoxication level in ESRD patient, the major impact of
UREA KINETIC MODELUKM as a quality-control tool was then established [8, 9].
Unfortunately, oversimplification of the “dialysis ade- Urea kinetic modeling was performed using the two-
quacy” concept to the “dialysis dose” index (Kt/V) led compartment model with a variable volume, and is pre-
to a dramatic reduction of dialysis time with the false sented in Figure 1. In this model, V1 and V2 represent
safety of numbers [10–14]. Short dialysis programs com- the distribution spaces equivalent to the extracellular
plying with timely Kt/V recommendations of ad hoc com- space (or accessible, superficial) and intracellular space
mittees contributed to underdialysis and its deleterious (or remote, deep), respectively. G is the urea generation
consequences on morbidity and mortality of the dialysis rate (mmol/min). Kc (mL/min) is the intercompartmental
patient [7, 15, 16]. Refinement of UKM based on direct urea mass transfer coefficient, and Keff (mL/min) is the
dialysis quantitation and online urea monitoring system dialyzer clearance.
(UMS) showed that urea kinetics was more complex than The mathematical equations of the two-compartment
initially described with single-pool (sp) models [17, 18]. model are as follows:
In particular, it was shown that trivial UKM sp models
X˙1(t) 5 KeffC1(t) 1 Kc[C2(t) 2 C1(t)] 1 G (Eq. 1)were overestimating dialysis efficacy by ignoring intra-
corporeal compartment urea disequilibrium phenome- X˙2(t) 5 2Kc[C2(t) 2 C1(t)] (Eq. 2)
non [19–23]. Shortcomings of sp UKM (Kt/Vsp) tended
where X1(t) and X2(t) are compartment masses of ureato be worsened by individual anthropometric and/or func-
(mmol/L). C1(t) 5 X1(t)/V1(t) and C2(t) 5 X2(t)/V2(t)tional differences such as urea distribution volume and
represent urea concentrations (mmol/L). The time-vary-intercompartment urea mass transfer coefficient [24, 25].
ing distribution volumes are calculated as V1(t) 5 fv1V(t)Underdialysis resulting from these combined effects led
and V2(t) 5 (1 2 fv1)V(t), where V(t) is the total distribu-to the deleterious effects on patient outcomes. Recent
tion volume and fv1 is the fraction of the volume of theurea kinetic studies have confirmed that a urea concen-
accessible compartment (V1). The volume V(t) is thetration profile resulting from intermittent hemodialysis
sum of the dry-weight distribution volume, Vtot, attainedfits multiple compartment models [26, 27]. The two-com-
at the end of the session and of the weight lost duringpartment model structure accounting for intracorporeal
the session to restore extracellular fluid volume throughdialysis disequilibrium and postdialysis rebound is pres-
ultrafiltration (rate Wloss), that is, V(t) 5 Vtot 1 DBW 2ently the only model that may adequately estimate urea
Wloss · t. The urea generation rate (G) was fixed to 167distribution volume and whole body clearance [28, 29].
mmol/min (10 mg/min) in all patients. Parameter esti-This complex modeling approach has been simplified
mates were obtained for each patient by simultaneousto fulfill the clinician’s needs to calculate the two-pool
fitting of all data collected for that individual duringequivalent using a bedside formulae [30–37].
different dialysis sessions. A typical graph of urea con-The purpose of our study was threefold: The first was
centration measurements provided by the UMS is pre-to assess reliability of a blood-side (ultrafiltrate) continu-
sented in Figure 2. The volume Vtot was the only parame-ous online UMS interfaced with a two-pool model in esti-
ter assumed constant over different dialysis sessions. Themating dialysis performances. The second was to evaluate
remaining estimated parameters were the predialysisthe in vivo patient intercompartment mass transfer coef-
ficient for urea (Kc), and the third was to compare online urea concentration C0 (mmol/L), the intercompartment
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Fig. 2. Time course of urea concentration
measurements (continuous line) and urea ki-
netic model fit (dashed line) and dialysis flow
rate, Qd.
Fig. 3. Schematic diagram of the paired fil-
tration dialysis (PFD) based on physical sepa-
ration of hemofiltration (HF) and hemodialy-
sis (HD). Abbreviations are: Qi, blood-water
flow at the dialyzer inlet; Quf, ultrafiltrate flow
rate, fPFD, fraction of Quf in HF; Qinf, reinfu-
sate flow rate; fpre, fraction of pre-infusion; Qd,
dialysate flow rate; Wloss 5 Quf 2 Qinf weight
loss rate; kd0, diffusive filter clearance; Ci and
Co, solute concentrations at the inlet and out-
let, respectively.
mass transfer coefficient Kc, the fraction fv1, and the mass Filter clearance
transfer coefficient KoA that characterizes the HD filter The total clearance, Keff for the PFD configuration
(Fig. 3). The estimates of parameter KoA were allowed shown in Figure 3, depends on the flow conditions, Qi,
to vary across different dialysis sessions, but the average Quf, Qinf, the flow fractions fPFD and fpre, and the diffusive
value was constrained in each patient to be equal to the filter clearance Kd0. The clearance Kd0 depends on the
median value of direct measurements obtained in our operative conditions such as the effective blood flow
cohort. through the dialyzer, the dialysate flow, Qd, and the mass
The mathematical model was implemented using the transfer area coefficient KoA. In our experiments, blood
simulation tool PANSYM, and parameter estimates flow passing the dialyzer was kept constant during each
session. A direct determination of the parameter KoAwere obtained by maximum likelihood data fitting [38].
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was obtained by equating the theoretical total clearance This quadratic equation has two solutions, the smaller
of which is the correct one:Keff theor 5 Keff (Qi, Qd, Quf, Qinf, fPFD, fpre, KoA) to the
experimentally measured instantaneous clearance given as:
a 5 (KcVtot 1 KeffV2)[1 2 {1 2 4KcKeffV1V2/(KcVtot
Keff meas 5 (QiCmeasi 2 QoCmeaso )/Cmeasi (Eq. 3) 1 KeffV2)2}1/2]/(2V1V2) (Eq. 10)
where Cmeasi and Cmeaso are measured inlet and outlet urea Since V1 5 fv1Vtot and V2 5 (1 2 fv1)Vtot, a can beconcentrations, and by solving with respect to KoA. calculated once the parameters Keff, Kc, fv1 and Vtot are
known. In particular, a becomes the following:Evaluation of dialysis efficiency
a 5 [Kc 1 Keff(1 2 fv1)] [1 2 {1 2 4KcKefffv1(1 2 fv1)To assess dialysis efficiency, as the Kt/V index we used
the natural logarithm of the ratio between initial and /(Kc 1 Keff(1 2 fv1))2}1/2]/[2fv1(1 2 fv1)Vtot]final urea mass: (Eq. 11)
Kt/V 5 log[X1(0) 1 X2(0)]/[X1(T) 1 X2(T)]
METHODS5 log[(Vtot 1 DBW) Co]/[VtotCeq(T)] (Eq. 4)
Study designwhere T represents the end of the dialysis session, and
The study was carried out in 13 stable hemodialysisCeq(T) represents the postdialysis equilibrated urea con-
patients in two dialysis facilities (Montpellier, France, 9centration. This urea removal index can be easily calcu-
patients; Novara, Italy, 4 patients). Each patient waslated by simulation, but to evaluate the effects on dialysis
studied for a minimum of nine consecutive dialysis ses-efficiency of the model parameters fv1 and Kc, we con-
sions. Only two patients had fewer observations (3 andsider in the following a simplified analysis to determine
7 sessions, respectively) because of technical reasons.an approximation of equation 4.
With unperturbed operation, urea kinetics can be ap-
Patient characteristicsproximated toward the end of a dialysis session by a
Thirteen stable ESRD patients (12 males and 1 fe-one-compartment model. Under the simplifying assump-
male) with a mean age of 54 6 16 years were enrolledtions of constant distribution volume and negligible urea
in this study. Time spent on dialysis prior the study wasgeneration rate, G, we consider a first-order dynamics
101 6 80 months. All patients were anuric. Native arte-for the total urea mass X(t) 5 X1(t) 1 X2(t), that is,
riovenous fistula was used for vascular access in 11 pa-
X(t) 5 2a[X1(t) 1 X2(t)] tients, and two patients had a polytetrafluoroethylene
(PTFE) graft. Access recirculation was virtually unde-5 2Keff X1(t)/V1 (Eq. 5)
tectable at the time of the study. Causal nephropathies
where a represents the fractional whole body urea clear- were as follows: chronic glomerulonephritis (5, 38%),
ance. The right hand side in equation 5 is the effective hypertensive and/or vascular nephropathy (3, 23%), dia-
urea removal rate from the body. From equation 5, we betes (1, 8%), and miscellaneous (4, 31%).
obtain that the urea masses X1(t) and X2(t) are, under
the one-compartment approximation, in a fixed ratio, or: Treatment schedule and operating dialysis conditions
Extracorporeal RRT was based on three paired filtra-X2(t) 5 X1(t) [Keff/(aV1) 2 1] (Eq. 6)
tion dialysis (PFD) sessions per week lasting three to four
This equation can be used to calculate X1(T) 1 X2(T) 5 hours monitored by a specific Multimat dialysis system
Vtot Ceq(T) in equation 4 by observing that from equation 6, (Bellco, Italy).
Paired filtration dialysis is a hemodiafiltration (HDF)X1(T) 1 X2(T) 5 X1(T) Keff/(aV1)
modality in which diffusive (D) and convective (C) solute
5 (Keff/a) C1(T) (Eq. 7) fluxes are physically separated by means of two filters
disposed in series, as shown in Figure 3. In the firstwhich C1(T) is directly measurable.
device (HF), ultrafiltrate is produced through a high-fluxTo calculate a, we observe that equation 6 must hold
hemofilter, while in the second device (HD), diffusivealso for the time derivatives:
clearances are obtained through a conventional low-flow
X˙2(t) 5 X˙1(t) [Keff/(aV1) 2 1] (Eq. 8) hemodialyzer. Online production of substitution fluid is
ensured by cold sterilization of fresh dialysate throughBy replacing equations 1 and 2 in equation 8, we obtain
a double ultrafiltration in series.the following condition on a:
The urea monitoring system was based on a differen-
a2V1V2 2 [Kc(V1 1 V2) 1 KeffV2]a 1 KcKeff 5 0 tial conductivity change obtained after degrading urea
by urease as previously described [39, 40]. Measurements(Eq. 9)
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Table 2. Dialysis dose and protein catabolic rate estimated from UMSTable 1. Hemodialyzer performances
KoA Keff Urea mass Urea TAC nPCR
Patient Kt/VUMS mmol SRI mmol/L g/kg/24 hPatient mL/min mL/min
1 49069 284612 1 1.6160.07 554668 0.8860.02 14.161.5 0.8860.10
2 1.1160.04 12926215 0.7260.02 28.463.2 1.6160.292 57560 288614
3 590647 243614 3 0.8860.06 11926161 0.6360.03 27.262.0 1.6160.31
4 1.3260.17 650693 0.8360.05 20.462.2 1.1560.164 6846128 242619
5 5156103 288611 5 1.0360.04 8076131 0.6860.02 23.163.1 1.1060.18
6 1.1560.04 467653 0.7360.02 10.260.8 0.5160.046 545649 277621
7 493644 271621 7 1.1460.10 7676148 0.7260.05 16.460.9 1.2360.84
8 1.3060.02 481690 0.7660.01 11.661.7 0.8760.098 502690 267612
9 613625 239619 9 1.1660.11 735673 0.7560.04 19.261.7 1.1760.11
10 1.3860.10 493694 0.8360.04 13.361.9 0.7860.1010 5846139 229632
11 469614 286619 11 1.1560.06 9476186 0.7460.03 19.962.3 1.4160.19
12 0.8260.21 5266128 0.5860.11 13.460.0 0.7660.1012 5646180 284623
13 64564 279634 13 1.4960.20 9106143 0.9060.06 23.362.7 0.9160.09
X6SD 1.2160.22 7576287 0.7560.09 18.766.0 1.1260.41X6SD 559665 267621
RESULTSand dialyzer settings were automatically stored in com-
puter files at one-minute intervals. Dialysis operating Two-compartment model accuracy
conditions set at the start of the dialysis session were As shown in Figure 2, the ultrafiltrate urea concentra-
maintained constant throughout the session, except for tion recorded by UMS followed a regular exponential
the dialysate flow, which was started 15 minutes after decline according to time. The urea concentration pre-
the beginning of the dialysis session and stopped after dicted by the double-pool (dp) urea kinetic model
45 minutes for 15 minutes, as shown in Figure 2. These (UKMdp) fitted well to the experimental measured data
two periods of low intradialytic clearance provide infor- by the UMS. Intradialytic urea rebound induced by clear-
mation on the patient’s initial urea concentration and ance reduction during actual dialysis (t 5 45 minutes)
urea rebound. To validate theoretical calculations of fil- fitted the model prediction perfectly. The urea mass
ter clearance, blood samples were collected simultane- transfer coefficient (Kc) obtained from this curve fitting
ously from the arterial and venous lines, and instanta- was an “effective” Kc integrating value for all tissues
neous urea dialyzer clearance was calculated. resistant in the body. Validity of the UKMdp model was
Double-chamber hemodiafilters and typical operating confirmed in the entire group of patients under several
conditions in the two centers were: Novara, Italy, SG5 ultrafiltration rate regimens. Predictive value of the
(HF polysulfone HF 0.55 m2; HD 5 hemophan, 1.6 m2; model was confirmed by the goodness of fit of the theo-
Bellco, Mirandola, Italy), Qb 5 350 mL/min, Qd 5 500 retical curve to the experimental patient data provided
mL/min, Quf 5 58 mL/min, fPFD 5 0.8, fpre 5 1 (preinfu- by the UMS. Modeled parameters were then used to
sion); and Montpellier, France, SG8 (HF polysulfone HF estimate the best individual dialysis performances and
0.55 m2, HD 5 synthetically modified cellulose), Qb 5 the patient’s permeability characteristics obtained during
400 mL/min, Qd 5 650 mL/min, Quf 5 65 mL/min, fPFD 5 actual dialysis, and were used to predict postdialysis urea
0.77, fpre 5 0 (postdilution). Effective duration of dialysis concentrations (rebound phase) for up to one hour.
sessions averaged 240 minutes (150 to 260 min).
Hemodialyzer performancesAnticoagulation of the extracorporeal circuit was en-
sured by means of standard heparin (loading dose and Dialyzer urea mass transfer coefficient (KoA) for the
maintenance dose) or low molecular weight heparin (ini- entire group of patients was 559 6 65 mL/min with an
tial loading dose) according to individual requirements. intraindividual variation of 20.2% (Table 1).
Effective dialyzer clearance (Keff) was 267 6 21 mL/min
Calculations for the entire group of patients, ranging from 229 6 32
Results are expressed as the mean 6 SD for normally to 288 6 14 mL/min, with an individual variation of 7%.
distributed values and the median value with lower and
Dialysis dose and protein catabolic rate estimatedhigher quintiles for the others. The Bland–Altman plot
from UMSwas used to evaluate relationship and tendency in groups
of values. The linear regression model was used to ana- Normalized body clearance (Kt/V) estimated from the
lyze the relationship between two groups of values. UMS was 1.21 6 0.22 for the entire group of patients,
Mathematical best-fitting method was performed with ranging from 0.82 6 0.21 to 1.61 6 0.07 with an individual
modeled values to fit experimental data obtained with variation of 18% (Table 2). Urea mass removed per
session was 757 6 287 mmol, ranging from 481 6 90 tothe UMS.
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Table 3. Dialysis efficiency versus week session
Urea mass % Urea TAC nPCR
Week mmol week mmol/L Kt/V SRI g/kg/24 h
1 8206295 36.0 19.766.0 1.2060.20 0.7660.08 1.0560.30
2 7376287 33.0 18.966.1 1.1960.24 0.7560.09 1.1160.37
3 7056271 31.0 17.465.8 1.2460.21 0.7660.08 1.1760.52
Table 4. Distribution volumes
Patient BW kg V Watson liters V Chertow liters Vtot liters V1 liters V1BW L/kg V1/Vtot V2 liters V2/BW L/kg V2/Vtot
1 65.6 30.5 32.3 27.4 6.0 0.09 0.22 21.4 0.33 0.78
2 75.8 41.8 44.8 42.6 11.3 0.15 0.26 31.4 0.41 0.74
3 70.5 40.7 46.5 49.3 7.4 0.10 0.15 41.9 0.59 0.85
4 53.7 36.5 37.9 24.6 6.8 0.13 0.28 17.8 0.33 0.72
5 72.5 37.6 42.1 35.1 7.8 0.11 0.22 27.3 0.38 0.78
6 98.9 47.4 53.5 40.9 8.3 0.08 0.20 32.6 0.33 0.80
7 82.5 41.3 45.8 41.3 10.0 0.12 0.24 31.3 0.38 0.76
8 58.5 34.2 37.0 35.0 10.9 0.19 0.31 24.1 0.41 0.69
9 62.3 35.7 38.4 34.5 8.0 0.13 0.23 26.5 0.43 0.77
10 63.5 35.1 37.8 29.0 5.4 0.09 0.19 23.5 0.37 0.81
11 71.0 41.1 44.1 43.8 11.7 0.16 0.27 32.2 0.45 0.73
12 74.0 40.2 45.9 46.5 13.3 0.18 0.29 33.2 0.45 0.71
13 90.0 45.9 47.9 45.3 10.4 0.12 0.23 36.4 0.40 0.80
X6SD 70.5611.7 38.564.4 42.665.7 38.167.8 9.062.4 0.1360.03 0.2460.04 29.266.6 0.4160.07 0.7660.04
1292 6 215 mmol. The solute removal index was 75.4 6 ratio (V1/V2) was, in this case, 31%, a value that differs
8.6% ranging from 58 6 11 to 90 6 6%. The urea time- from the 50% (1/2) commonly accepted.
averaged concentration (UreaTAC) was 18.7 6 6 mmol/L. Effective urea mass transfer coefficient (Kc) was 912 6
nPCR calculated from the urea mass generated was 255 mL/min [857 6 235 mL/min normalized to 1.73/body
1.12 6 0.41 g/kg/24 hours ranging from 0.51 6 0.04 to surface area (BSA)]. Individual Kc values are presented
1.61 6 0.31 g/kg/24 hours. according to the box-plot method in Figure 4. Intrapa-
tient variability over time averages 30% (12 to 91%).
Impact of weekly dialysis session number for Large differences were observed among patients ranging
dialysis efficiency from low 363 6 333 to high Kc values 1113 6 277 mL/
Dialysis efficiency was analyzed according to the num- min. Individual mean Kc patient values were ranked by
ber of dialysis sessions in a week (Table 3). Weekly urea quartiles and are presented in Figure 5. As shown, Kc
mass removed was 2283 6 833 mmol in which 36, 33, median value was 902 mL/min, while the upper limit of
and 31% were removed at the first, second, and third lower quartiles (Q2, 50) was 739 mL/min, and the lower
sessions of the week, respectively. Neither Kt/V, SRI, nor limit of the upper quartiles (Q3, 75) was 973 mL/min.
nPCR differed significantly according to dialysis session Such boundary limits may be used for stratifying patients
number. UreaTAC was 19.7, 18.9, and 17.4 mmol/L for as a function of their internal permeability and resistance
the first, second, and third dialysis cycles of the week, to urea diffusion. Schematically, three groups of patients
respectively. may be identified: normal-permeable patient, 739 5 Kc ,
1100 mL/min; high-permeable patient, 1100 mL/min 5
Patient characteristics Kc; and low-permeable patient, Kc , 739 mL/min. From
this in vivo measurement of Kc, one may conclude theIndividual characteristics calculated from UKMdp mod-
following: First, Kc is a personal characteristic that differseling are presented and compared with anthropometric
widely from patient to patient, and second, within-patientderived parameters (Tables 4 and 5) [41].
Kc variability denotes changes in internal solute transferTotal urea distribution volume (Vtot) was 38.1 6 7.8 L,
resistance that are hemodialysis induced.which is 53 6 8% of dry body weight. Extracellular or
Postdialysis rebound, an individual characteristic, mayaccessible volume (V1) was 9.0 6 2.4 L (13 6 3% body
be accurately predicted from in vivo Kc value. As shownweight), and intracellular or remote volume (V2) was
in Figure 6, a negative linear relationship was estab-29.2 6 6.6 L (41 6 7% body weight), representing 24 6
lished when 30-minute postdialysis rebound was plotted4% and 76 6 4% of the total urea distribution volume,
respectively. The extracellular to intracellular volume against Kc.
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Table 5. Urea mass transfer coefficients and rebound
Kc CV BSA nKt
Patient mL/min % m2 mL/min/1.73 m2 Rebound 30 Rebound 60
1 6876122 17.8 1.70 7006125 0.2260.08 0.2660.08
2 9896168 17.0 1.91 8986153 0.1360.04 0.1560.04
3 12496146 11.7 1.90 11356132 0.0860.06 0.0960.06
4 6466319 49.4 1.59 7036347 0.1460.10 0.2060.17
5 8376163 19.5 1.85 7816153 0.1560.06 0.1760.07
6 11136277 24.9 2.21 8706217 0.1560.06 0.1760.06
7 10476321 30.7 1.98 9146280 0.1260.06 0.1460.06
8 7576110 14.6 1.65 7956116 0.1460.05 0.1760.06
9 9736235 24.2 1.70 9906239 0.1060.06 0.1260.06
10 12826438 34.2 1.71 13006444 0.1160.06 0.1460.07
11 9896312 31.5 1.86 9226290 0.0960.05 0.1160.05
12 9266269 29.1 1.92 8326242 0.1260.04 0.1460.06
13 3636333 91.6 2.06 3066280 0.2360.12 0.3360.18
X6SD 9126255 30.5 1.82 8576235 0.1460.05 0.1760.07
Fig. 4. Box plot of the estimated urea mass
transfer coefficients in different patients.
Fig. 5. Quartile plot of the average urea mass
transfer coefficients in different patients.
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Fig. 6. Fraction of post-dialysis rebound at 30
minutes versus urea mass transfer coefficient.
Fig. 7. Comparison of cumulative estimates
of Kt/V according to various bedside formulae
based on (A) (sp) single- and (B) (db) double-
pool models. The predicted urea modeling
system (UMS) is based on a simplified urea
kinetic modeling (UKM) formula proposed in
this study, and the measured UMS is based
on a model simulation (Eq. 4).
Comparison with bedside formulae between the two estimates comes down to 0.11. Interest-
ingly, Kt/V, computed from urea concentration, sampledKt/V indices, calculated from two-blood samples (pre-
30 minutes (C230) before the end of dialysis was virtuallydialysis/postdialysis samples), using the main formulae
identical to equilibrated Kt/V (Fig. 9) [42]. No significant(sp and dp), were compared with those obtained with
difference was observed between the Kt/Vdp equilibratedthe UMS (Fig. 7). The Kt/Vsp formulae (Fig. 7A) tended
formulae proposed by Daugirdas and Tattersall (Fig. 10)to overestimate Kt/VUMS by 30%, while the Kt/Vdp formu-
[32, 36].lae (Fig. 7B) were close to the Kt/VUMS. This is shown
Normalized PCRs, calculated from urea mass, re-in Figure 8, in which Kt/V obtained from the Daugirdas
moved per session according to UKMdp using the Borah’sequilibrated formula and UMS are compared using the
Bland–Altman method. As shown, the mean difference relationship, were compared with simplified formulae
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Fig. 8. Bland-Altman plot comparing indi-
vidual double-pool Kt/V estimates obtained
by UMS and kinetic modeling, and by the
Daugirdas equilibrated formula.
Fig. 9. Comparison of double-pool Kt/V ob-
tained using C-30 as an estimate of the equili-
brated urea concentration and the Daugirdas
equilibrated formula.
(preurea/posturea samples; Table 6) [43]. Interestingly, requiring input of several estimated parameters and use
of a personal computerized system. To meet quality con-the simplified two-point formulae gave virtually similar
trol needs and to help clinicians assess dialysis dose deliv-results compared with modeled UMS values.
ery, two types of tools have been developed. One relies
on urea monitoring sensors implemented on the dialy-
DISCUSSION sate (dialysate-side monitors) or the ultrafiltrate (blood-
The two-compartment model is now the basic struc- side monitors) lines, and the other uses two-point simpli-
ture commonly recognized to describe better intermittent fied bedside formulae with predialysis and postdialysis
hemodialysis-associated urea kinetics in ESRD patients urea concentrations and the usual parameters such as
[44]. Double-pool UKM (UKMdp) remains quite com- body weight, weight loss, and dialysis duration [45, 46].
Online urea monitoring devices providing a direct analy-plex, however, relying on questionable assumptions and
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Fig. 10. Comparison of the double-pool Kt/V
obtained from the formulae by Tattersall and
Daugirdas.
Table 6. Normalized protein catabolic rates equivalent (Kt/Vdp) incorporating correcting factors for
this intradialytic compartment disequilibrium has beenUMS-Borah Garred Depner
Patient g/kg/24 h g/kg/24 h g/kg/24 h proposed more recently [49, 50]. Indeed, several studies
1 0.8860.10 0.9760.10 1.1560.13 have confirmed that the dialysis dose estimate made by
2 1.6160.29 1.6360.29 1.6460.15 the last generation of two-point formulae was in good
3 1.6160.31 1.6160.31 1.3460.15
agreement with direct dialysis quantitation and/or online4 1.1560.16 1.2860.16 1.3860.11
5 1.1060.18 1.1560.18 1.2960.18 urea monitoring sensors using the dp model [51–57]. For
6 0.5160.04 0.5360.04 0.7060.04 this reason dp equivalent Kt/V formulae are proposed
7 1.2360.84 1.2560.84 1.0860.20
as a reference method to assess dialysis dose delivery [58].8 0.8760.09 0.9460.09 0.8660.08
9 1.1760.11 1.2460.11 1.2060.09 Accuracy of this simplified dp equivalent UKM approach
10 0.7860.10 0.8760.10 0.9760.08 remains controversial, however, in several circumstances
11 1.4160.19 1.4360.19 1.2060.17
such as the high-efficiency short dialysis session, large12 0.7660.09 0.7660.10 0.6860.10
13 0.9160.09 0.9860.09 1.1760.23 ultrafiltration rate, and overweight patient [59–62]. In-
X6SD 1.0860.33 1.1360.32 1.1360.27 deed, this quite simple approach is not able to tailor for
factors affecting dialysis dose delivery such as urea distri-
bution volume, intensity of dialysis efficacy, changes in
intercompartment urea mass transfer coefficient, or en-
sis of urea kinetics with a mathematical fitting to a two- hanced urea generation rate [63–65].
pool model have enlarged the possibilities for an accu- Because of the lack of information of bedside formu-
rate dose quantitation in dialysis. Despite their interest lae, we surmised that implementing a two-compartment
as a quality control tool, these monitoring devices are still model, variable volume, on continuous UMS would pro-
limited to the field of research work. Blood-side approach, vide a new and more accurate approach to quantitate in
based on predialysis and postdialysis urea concentrations vivo dialysis performances. As shown, the UKMdp model
and simplified formulae to calculate urea reduction ratio was strong enough to forecast precise urea concentration
or sp Kt/V, is indeed the currently recommended practice profile from a limited number of estimated parameters.
by the DOQI guidelines. The weakness of this later ap- The usual difficulty in validating such model, because of
proach lies in the immediate postdialysis urea concentra- the scarcity of experimental data, was solved in our study
tion that is not in equilibrium with the intracellular vol- thanks to the continuous information provided by the
ume, and tends to overestimate the true efficacy of the UMS. By using prior information to fix values of model
dialysis session [47, 48]. A second generation of bedside parameters and by extracting additional information
from simultaneous analyses of experimental data col-formulae, referring to postdialysis “equilibrated” or “dp”
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lected on patients, UKMdp permitted a precise estimate visable to tailor treatment time and/or dialysis periods to
the Kc value in order to optimize dialysis dose delivery.of urea dynamics both in the intracellular and the extra-
cellular compartments. By combining continuous moni- Individual patient variability of Kc over time is also
a new and quite interesting finding. Within-patient Kctoring of plasma urea concentration (urea concentration
in the ultrafiltrate was measured every minute), data changes denote physiological modifications in the inter-
compartment urea transfer resistance that are hemodial-storage in a personal computer, and mathematical model
fitting, it was then possible to apply the theoretical pre- ysis-induced. True Kc is the consequence of in vivo factors
modulating resistance to urea transfer such as regionaldictions made by the UKMdp individually to each patient.
Moreover, the noninvasive aspect of this study permitted tissue perfusion differences, compartment volume changes,
and the cardiopulmonary recirculation effect. In vivo Kcrepeating the experiment in each patient for variability
analysis up to nine consecutive dialysis sessions. may be therefore considered as a lumped factor integrat-
ing both regional blood flow model considerations andIn all experiments, urea kinetics obtained from the
UMS fitted closely to the UKMdp model predictions (Fig. internal tissue resistance to urea transport between body
compartments.2). Interestingly, this simplified version of the two-com-
partment, variable-volume model provides similar infor- Urea distribution volume and compartments esti-
mated from UKMdp are other quite original and interest-mation to more complex models that were tested pre-
viously, accounting for cardiopulmonary and vascular ing findings of this study. For the entire cohort, the total
urea distribution volume was Vtot 5 38.1 6 7.8, which isaccess recirculation or based on a three-compartment
structure (results not shown). 53 6 8% of dry weight, a value close to published data.
The two compartments of the model, referring to V1Online UKMdp gave a new insight into the urea kinetic
approach, since, to our knowledge for the first time, it for the extracellular volume and V2 for the intracellular
volume, were equal to 9 6 2 L (13 6 3% body weight)provides a true in vivo individual estimate of modeled
parameters with their own variability. Taking advantage and 29.2 6 6.6 L (41 6 7% body weight), respectively.
The ratio extracellular/intracellular (V1/V2) was equal toof the ease to use and its accuracy, the dual function of
the UKMdp monitoring device was used to explore both 0.31 (one third), differing from the fixed and paradigm
value of 0.50 (one half). This observation confirms thesides of the patient/hemodialysis system.
Direct in vivo measurement of intercompartment urea fact that the two-compartment concept based on “ana-
tomical” division is not applicable to dialysis. It wouldtransfer coefficient referring to an effective Kc was
achieved in a group of 13 stable ESRD patients who may be more appropriate to define two “functional” compart-
ments referring to V1 as an “accessible” (or superficial)be considered to be representative of a normal dialysis
population. The effective Kc for the entire cohort of pa- compartment and to V2 as a “remote” (deep) compart-
ment. As shown in this study, V1 or accessible volumetients was 912 6 255 mL/min (857 6 235 mL/min normal-
ized to 1.73 m2), a value close to the reported ones obtained was smaller than the predicted extracellular volume
(20% body weight, 15 L) but was larger than the circulat-with more invasive methods [66, 67]. Large variations
were observed among patients, with Kc values ranging ing volume (5% body weight, 5 L) [68]. Such an observa-
tion strongly suggests that V1 is a variable parameterbetween 363 and 1249 mL/min. Such a finding is not
astonishing and clearly reflects the difference existing in largely depending on hemodynamic state (effective vo-
lemia) and peripheral tissue perfusion of the hemodialy-individual internal urea patient permeability. Using the
in vivo Kc value, ESRD patients then may be stratified sis patient.
Finally, this study offers an indirect validation of theaccording to their intercompartment urea diffusibility.
Schematically, three groups of patients were identified: simplified two-compartment equivalent formulae in as-
sessing dialysis dose delivered and nPCR based on athe medium- or normal-permeable patient 740 5 Kc 5
1100 mL/min; the high-permeable patient Kc . 1100 mL/ two blood samples. As shown, the first generation sp
formulae overestimates the true Kt/V value by 30% andmin; and the low-permeable patient Kc , 740 mL/min.
Patient permeability differences, as reflected by Kc val- should be replaced by equilibrated formulae that better
fit the double-pool model estimate. Interestingly, it wasues, are implied during the setup of the intercompart-
ment urea gradient during dialysis and its rapid correc- confirmed that, 30 minutes before the end of dialysis,
the urea concentration was virtually identical to the 30-tion in the postdialysis phase (rebound). This is clearly
illustrated by the negative linear relationship established minute postdialysis equilibrated value. By using the C-30
urea concentration as the postdialysis sample estimate, itbetween in vivo Kc and postdialysis rebound (Fig. 6).
In other words, the highly permeable patient will have was possible to calculate a Kt/Vdp equivalent in a simple
fashion. nPCR calculated from urea mass, removed withmarginal postdialysis rebound, while the low-permeable
patient will have significantly higher postdialysis rebound. the UMS, was found to be very close to that obtained
with simplified two-point formulae.According to this observation, it now becomes highly ad-
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G: Comparison of urea kinetics and direct dialysis quantificationCONCLUSIONS
in hemodialysis patients. Trans Am Soc Artif Intern Organs 31:338–
341, 1985A blood-side online urea monitoring device interfaced
19. Pedrini LA, Zereik S, Rasmy S: Causes, kinetics and clinical impli-with a two-compartment model offers a more complete
cations of post-hemodialysis urea rebound. Kidney Int 34:817–824,
picture of urea dynamics in hemodialysis patients. By 1988
20. Buur T: Precision of hemodialysis urea kinetic modeling: Empiri-using this noninvasive monitoring device, it becomes pos-
cal data and Monte Carlo simulation. Comput Methods Programssible to assess in vivo both dialysis efficacy and modeled
Biomed 35:25–34, 1991
patient characteristics, for the first time to our knowledge 21. Flanigan MJ, Fangman J, Lim VS: Quantitating hemodialysis: A
comparison of three kinetic models. Am J Kidney Dis 17:295–302,giving a tool for internal monitoring of the dialysis pa-
1991tient. Urea kinetic analysis performed in this study con-
22. Bankhead MM, Toto RD, Star RA: Accuracy of urea removal
firmed that urea dynamics fits perfectly well with a dou- estimated by kinetic models. Kidney Int 48:785–793, 1995
23. Levine J, Bernard DB: The role of urea kinetic modeling, TAC-ble-compartment model. The original findings from the
urea, and Kt/V in achieving optimal dialysis: A critical reappraisal.modeled parameters include: First, the accessible volume
Am J Kidney Dis 15:285–301, 1990
(V1) was found to be smaller than expected with a ratio 24. Canaud B, Bosc JY, Vaussenat F, Leray-Moragues H, Leblanc
M, Garred LJ, Mion Ch: Quantitation in hemodialysis: Adequacyof V1/V2 of one third; second, in vivo measurement of the
measurement revisited. Semin Dial 12:370–375, 1999intercompartment urea mass transfer coefficient (effective
25. Pflederer BR, Torrey C, Priester-Coary A, Lau AH, Daugir-
Kc 5 912 mL/min) confirmed that Kc was an individual das JT: Estimating equilibrated Kt/V from an intradialytic sample:
Effects of access and cardiopulmonary recirculations. Kidney Intand functional characteristic subject to variation.
48:832–837, 1995
26. Depner TA: Prescribing Hemodialysis: A Guide to Urea Modeling.Reprint requests to Bernard Canaud, M.D., Nephrology Department,
Lapeyronie University Hospital, 34295 Montpellier, France. Boston, Kluwer Academic Publisher, 1993, pp 39–126
27. Yamada T, Akiba T, Marumo F: One-compartment urea kineticE-mail: b-canaud@chu-montpellier.fr
modeling is not acceptable for quantifying the adequacy of hemodi-
alysis: Comparison of a one-compartment model with a two-com-
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